Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
Part of paid clinical trials in Overland Park, Kansas.
- Sponsor
- Kansas City Heart Rhythm Research Foundation
- Study ID
- NCT06078735
- Status
- Recruiting
Conditions
- Atrial Fibrillation
- Hemostasis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Vascular closure with LockeT device — DEVICEFor subjects that are assigned to the LockeT device arm, the healthcare professional will place the LockeT with suture above the wound to achieve compression instead of manually holding pressure on the sutures. After hemostasis is achieved and prior to ambulation the LockeT will be removed followed by suture removal.
Study Details
The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
Key Dates
- Start date
- Oct 2, 2023
- Status verified
- Oct 2024
- Primary completion
- Dec 31, 2024
- Completion
- Dec 31, 2024
Study Design
- Enrollment
- 110 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: LockeTThese are the patients assigned for LockeT device arm to close the access site wound.
- No Intervention: Manual compressionThese are the patients assigned for Manual Compression arm to close the access site wound.
Primary Outcome Measure
Effectiveness of using the LockeT suture retention device [ Time Frame: 2 Days ]
Central Contacts
- Donita Atkins816-651-1969
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kansas City Heart Rhythm Institute - Roe Clinic | Overland Park | Kansas | 66211 | Dhanunjaya Lakkireddy, MD (PRINCIPAL_INVESTIGATOR) |
| Overland Park Regional Medical Center | Overland Park | Kansas | 66215 | |
| Centerpoint Medical Center | Independence | Missouri | 64057 | |
| Centerpoint Medical Center Clinic | Independence | Missouri | 64057 | |
| Research Medical Center | Kansas City | Missouri | 64032 | Naga Venkata K. Pothineni, MD (PRINCIPAL_INVESTIGATOR) |
| Research Medical Center Clinic | Kansas City | Missouri | 64032 | Naga Venkata K. Pothineni, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Overland Park, KS
By condition
By specialty
By research site
Kansas City Heart Rhythm Institute - Roe Clinic· Overland Park, KSOverland Park Regional Medical Center· Overland Park, KSCenterpoint Medical Center· Independence, MOCenterpoint Medical Center Clinic· Independence, MOResearch Medical Center· Kansas City, MOResearch Medical Center Clinic· Kansas City, MO
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac SurgeryRecruiting · Tulane University · Covington, Louisiana
- Tracking Results of Ablations to Combat AF Registry Generation 2Recruiting · AtriCure, Inc. · Huntsville, Alabama